When was Thermo Fisher Scientific Inc. founded?

Thermo Fisher Scientific Inc. was formed on November 9, 2006, as a result of a merger between Thermo Electron Corporation and Fisher Scientific International Inc.

Where is the company’s stock listed and what symbol does it trade under?

Thermo Fisher Scientific Inc. is listed on the New York Stock Exchange and is traded under the symbol “TMO.”

What is the CUSIP number for the company’s common stock?

The CUSIP number for the common stock of Thermo Fisher Scientific Inc. is 883556 10 2.

Who is the transfer agent for Thermo Fisher Scientific Inc. common stock?

American Stock Transfer & Trust Company is the transfer agent. You may contact them as follows:
by phone 1-800-937-5449 within the US or 1-718-921-8124 outside of the US
on the Web www.amstock.com
in writing at Operations Center, 6201 15th Avenue, Brooklyn, NY 11219

Whom do I contact for lost stock certificates, address changes, change of ownership and questions on stock certificates?

Contact Thermo Fisher Scientific Inc.’s transfer agent: American Stock Transfer & Trust Company. You may contact them as follows:
by phone 1-800-937-5449 within the US or 1-718-921-8124 outside of the US
on the Web www.amstock.com
in writing at Operations Center, 6201 15th Avenue, Brooklyn, NY 11219

Does Thermo Fisher Scientific Inc. pay a dividend?

Yes, please see the Dividends page of the company’s website for detail.

Future declarations of dividends are subject to board approval and may be adjusted as business needs or market conditions change.

Does Thermo Fisher Scientific Inc. have a dividend reinvestment plan or a direct stock purchase plan?

No, Thermo Fisher Scientific Inc. has neither a dividend reinvestment plan nor a direct stock purchase plan.

How can I buy or sell shares of Thermo Fisher Scientific Inc.?

Please contact your financial institution or brokerage firm in order to buy or sell shares.

Has Thermo Fisher Scientific Inc. ever had a stock split?

Since Thermo Fisher Scientific Inc. was formed in 2006, it has not had a stock split. Please see the Historical Price Lookup page for a list of historical TMO stock splits.

How can I research my historical cost basis on Thermo Fisher Scientific Inc., Fisher Scientific International Inc., Dionex Corporation and/or Life Technologies Corporation shares?

Please see the Historical Price Lookup page on Thermo Fisher Scientific Inc.’s website for detail.

How do I calculate the tax basis for shares I received in Kadant Inc.?

To calculate your tax basis for your current holdings, please refer to guidance given in the following letter to shareholders. Additionally, please refer to the tax basis worksheet to assist you with your calculations.

How do I calculate the tax basis for shares I received in Viasys Healthcare Inc.?

To calculate your tax basis for your current holdings, please refer to guidance given in the following letter to shareholders. Additionally, please refer to the tax basis worksheet to assist you with your calculations.

How do I contact Investor Relations?

Thermo Fisher Scientific Inc.’s Investor Relations Department can be contacted by calling 800-678-5599 within the U.S. and 1-781-622-1111 from outside the U.S. You may also email investorrelations@thermofisher.com.

What are the classes and amounts of securities sought in the Offer?

Thermo Fisher is offering to purchase all outstanding shares of Patheon at a purchase price of $35.00 per share, less any applicable withholding taxes and without interest, to the holders thereof, in cash, upon the terms and subject to the conditions set forth in the Offer to Purchase and the Letter of Transmittal (the “Offer”).

Why is Thermo Fisher making the Offer?

Thermo Fisher is making the Offer because it wants to acquire the entire equity interest in Patheon so that it will own and control all of Patheon’s current businesses. If the Offer is consummated, Thermo Fisher intends to cause Patheon to terminate the listing of the Shares on the New York Stock Exchange (‘‘NYSE’’).  As a result, Patheon and its shares would cease to be publicly traded.  In addition, after the consummation of the Offer, Thermo Fisher intends to cause the termination of the registration of shares under the Securities Exchange Act of 1934 as promptly as practicable, and expects to take steps to cause the suspension of all of Patheon’s reporting obligations with the SEC. 

How much is Thermo Fisher offering to pay and what is the form of payment? Will I have to pay any fees or commissions?

Thermo Fisher is offering to pay $35.00 per share, less any applicable withholding taxes and without interest, to the holders thereof, payable in cash, upon the terms and subject to the conditions set forth in the Purchase Agreement and in the Offer to Purchase and the Letter of Transmittal. If you are the record owner of your shares and you tender your shares directly to American Stock Transfer & Trust Company, LLC (the ‘‘Depositary’’), you will not have to pay brokerage fees, commissions, or similar expenses. If you own your shares through a broker, dealer, commercial bank, trust company, or other nominee and your broker, dealer, commercial bank, trust company, or other nominee tenders your shares on your behalf, your broker, dealer, commercial bank, trust company, or nominee may charge you a fee for doing so. You should consult your broker, dealer, commercial bank, trust company, or nominee to determine whether any charges will apply.

What does the Board of Directors of Patheon think of the Offer?

After careful consideration, the board of directors of Patheon (the ‘‘Patheon Board’’) has unanimously, among other things, (a) determined that the Offer, the Purchase Agreement and the transactions contemplated by the Purchase Agreement (including the Asset Sale and the Liquidation and Second Step Distribution (each as defined in the Purchase Agreement)) are in the best interests of Patheon, its business and its shareholders, employees and other relevant stakeholders and (b) approved the Offer, the Purchase Agreement (including the execution, delivery and performance thereof) and the transactions contemplated by the Purchase Agreement. The Patheon Board unanimously recommends that Patheon shareholders accept the Offer and tender their Shares in the Offer.

How long do I have to decide whether to tender my Shares pursuant to the Offer?

You will have until 9:00 a.m., New York City time, on August 10, 2017, unless Thermo Fisher extends the Offer in accordance with the Purchase Agreement or the Offer is earlier terminated. Furthermore, if you cannot deliver everything that is required in order to make a valid tender in accordance with the terms of the Offer by that time, you may still participate in the Offer by using the guaranteed delivery procedure that is described in the Offer to Purchase.

Please give your broker, dealer, commercial bank, trust company, or other nominee instructions with sufficient time to permit such broker, dealer, commercial bank, trust company, or other nominee to tender your shares in accordance with your instructions. Beneficial owners should be aware that their broker, dealer, commercial bank, trust company, or other nominee may establish its own earlier deadline for participation in the Offer. Accordingly, beneficial owners wishing to participate in the Offer should contact their broker, dealer, commercial bank, trust company, or other nominee as soon as possible in order to determine the times by which such owner must take action in order to participate in the Offer.

Have any Patheon shareholders already agreed to tender their Shares in the Offer?

Yes. In order to induce Thermo Fisher and Purchaser to enter into the Purchase Agreement, concurrently with the execution and delivery of the Purchase Agreement, JLL Patheon Co-Investment Fund L.P., certain other affiliates of JLL Partners LLC, Koninklijke DSM N.V. and JLL/Delta Patheon Holdings L.P. (together, the ‘‘Majority Shareholders’’), including Patheon Holdco Coöperatief U.A. (which holds certain shares for the benefit of certain employees of Patheon), entered into separate tender and support agreements with Thermo Fisher and Purchaser (collectively, the ‘‘Tender and Support Agreements’’). Shares owned by the Majority Shareholders subject to the Tender and Support Agreements comprise, in the aggregate, approximately 75% of the outstanding Shares. Subject to the terms and conditions of the Tender and Support Agreements, the Majority Shareholders have agreed, among other things, to tender their Shares in the Offer and to vote in favor of all resolutions proposed for adoption by Patheon shareholders at the extraordinary general meeting of Patheon shareholders. The Majority Shareholders have also agreed not to solicit competing proposals or transfer any of their shares without the prior written consent of Thermo Fisher (subject to certain permitted exceptions).

How do I tender my shares?

In order for your shares to be validly tendered pursuant to the Offer, you  must follow these instructions:

If your shares are directly registered in your own name in Patheon’s shareholders register (including if you are a record holder and you hold shares in book-entry form on the books of Patheon’s transfer agent)

  • The following must be received by the Depositary at one of its addresses in the Letter of Transmittal prior to the Expiration Time (as defined in the Offer to Purchase):
    • the Letter of Transmittal, properly completed and duly executed, and
    • any other documents required by the Letter of Transmittal.

If your shares are held in ‘‘street’’ name and are being tendered by book-entry transfer into an account maintained by the Depositary at The Depository Trust Company

  • The following must be received by the Depositary at one of its addresses in the Letter of Transmittal prior to the Expiration Time (as defined in the Offer to Purchase):
    • the Letter of Transmittal, properly completed and duly executed, or an Agent’s Message (as defined in the Offer to Purchase);
    • a Book-Entry Confirmation (as defined in the Offer to Purchase’); and
    • any other documents required by the Letter of Transmittal.

What if I cannot complete the procedure for delivery by book-entry transfer on a timely basis, or cannot deliver all of the required documents prior to the Expiration Time (as defined in the Offer to Purchase)?

  • You may be able to tender your shares using the Notice of Guaranteed Delivery enclosed in the Offer to Purchase.
  • For the tender to be valid, however, the Depositary must receive the Notice of Guaranteed Delivery prior to the Expiration Time (as defined in the Offer to Purchase) and must then receive the missing items within three NYSE trading days after the date of execution of Notice of Guaranteed Delivery.
  • Contact D.F. King & Co., Inc., the information agent for the Offer, for assistance. 

What should I do if I hold Shares through a broker, dealer, commercial bank, trust company or other nominee?

You must contact your broker, dealer, commercial bank, trust company or other nominee and give instructions that their shares be tendered.

How should the necessary documents be delivered or transmitted?

  • The Notice of Guaranteed Delivery may be delivered by courier or transmitted by facsimile transmission (but only by Eligible Institutions (as defined in the Offer to Purchase)) or mailed to the Depositary and must include a guarantee by an Eligible Institution in the form set forth in the form of Notice of Guaranteed Delivery.
  • In the case of shares held through The Depository Trust Company, the Notice of Guaranteed Delivery must be delivered to the Depositary by a participant by means of the confirmation system of The Depository Trust Company.
  • The method of delivery of the Letter of Transmittal and all other required documents, including delivery through The Depository Trust Company, is at the option and risk of the tendering shareholder, and the delivery of all such documents will be deemed made only when actually received by the Depositary (including, in the case of a book-entry transfer, receipt of confirmation of a book-entry transfer into the Depositary’s account at The Depository Trust Company).
  • If delivery is by mail, registered mail with return receipt requested, properly insured, is recommended. In all cases, sufficient time should be allowed to ensure timely delivery prior to the Expiration Time (as defined in the Offer to Purchase).

Who will determine if my shares have been validly tendered?

All questions as to the validity, form, eligibility (including time of receipt), and acceptance for payment of any tender of Shares will be determined by Thermo Fisher’s acquisition subsidiary, Thermo Fisher (CN) Luxmebourg S.à r.l (“Purchaser”), in its sole discretion.

How will I be notified/receive the Offer to Purchase and related Letter of Transmittal?

  • Patheon has provided Thermo Fisher and Purchaser with the Patheon shareholder list and security position listings for the purpose of disseminating the Offer to Purchase, the related Letter of Transmittal, and other related materials to Patheon shareholders.
  • The Offer to Purchase and the Letter of Transmittal, together with the Schedule 14D-9, will be mailed to record holders of shares whose names appear on the Patheon shareholder list and will be furnished, for subsequent transmittal to beneficial owners of shares, to brokers, dealers, commercial banks, trust companies, and other nominees whose names, or the names of whose nominees, appear on the Patheon shareholder list or, if applicable, who are listed as participants in a clearing agency’s security position listing for subsequent transmittal to beneficial owners of Shares.

When did the acquisition of Affymetrix, Inc. officially close?

The acquisition officially closed on March 31, 2016.

What will I receive in exchange for my Affymetrix, Inc. shares?

In accordance with the terms of the merger agreement, Affymetrix, Inc. shareholders will receive $14.00 in cash per common share.

I hold shares of Affymetrix, Inc. When can I expect to receive payment for my shares?

If you are a shareholder and have a stock certificate, you will receive a letter of transmittal from American Stock Transfer and Trust Company (AST). They will be mailed out on/about April 4, 2016. You will need to complete the forms contained in the mailing and return them to AST to receive payment.

If you are a shareholder who owns shares beneficially through a bank or broker, the funds were transferred to DTC on April 1, 2016, and will be disseminated to all banks and brokers accordingly. Please check your account or contact your broker for more details.

I hold some of my shares of Affymetrix, Inc. common stock in certificate form. Do I need to do anything with my Affymetrix stock certificate(s)?

Yes. You will need to surrender your Affymetrix, Inc. stock certificate(s) to the Exchange Agent, American Stock Transfer & Trust Company (AST). If you hold physical stock certificate(s), you will be receiving a separate mailing from AST for this transaction, with detailed instructions on how to exchange your Affymetrix, Inc. stock certificate(s).

What do I do if I hold shares of Affymetrix, Inc. common stock with my broker or custodian bank?

Your broker or custodian bank will exchange them for you. Please contact them directly for verification.

Who should I contact if I have questions about the exchange of my Affymetrix, Inc. common stock?

Any questions regarding the exchange of Affymetrix, Inc. common stock should be directed to American Stock Transfer & Trust Company, the Exchange Agent. You may contact them as follows:

-by Phone 1-800-937-5449 within the US or 1-718-921-8200 outside of the US
-on the Web www.amstock.com
-in writing at Operations Center, 6201 15th Avenue, Brooklyn, NY 11219

How can I research my historical cost basis on Affymetrix, Inc. shares?

Please see the Historical Price Lookup page on Thermo Fisher Scientific Inc.’s website for detail.

When did the acquisition of FEI Company officially close?

The acquisition officially closed on September 19, 2016.

What will I receive in exchange for my FEI Company shares?

In accordance with the terms of the merger agreement, FEI Company shareholders will receive $107.50 in cash per common share.

I hold shares of FEI Company. When can I expect to receive payment for my shares?

If you are a shareholder and have a stock certificate, you will receive a letter of transmittal from American Stock Transfer and Trust Company (AST). They were mailed out on September 22, 2016. You will need to complete the forms contained in the mailing and return them to AST to receive payment..

If you are a shareholder who owns shares beneficially through a bank or broker, the funds were transferred to DTC on September 21, 2016, and will be disseminated to all banks and brokers accordingly. Please check your account or contact your broker for more details.

I hold some of my shares of FEI Company common stock in certificate form. Do I need to do anything with my FEI stock certificate(s)?

Yes. You will need to surrender your FEI Company stock certificate(s) to the Exchange Agent, American Stock Transfer & Trust Company (AST). If you hold physical stock certificate(s), you will be receiving a separate mailing from AST for this transaction, with detailed instructions on how to exchange your FEI Company stock certificate(s).

What do I do if I hold shares of FEI Company common stock with my broker or custodian bank?

Your broker or custodian bank will exchange them for you. Please contact them directly for verification.

Who should I contact if I have questions about the exchange of my FEI Company common stock?

Any questions regarding the exchange of FEI Company common stock should be directed to American Stock Transfer & Trust Company, the Exchange Agent. You may contact them as follows:

  • by Phone 1-800-937-5449 within the US or 1-718-921-8200 outside of the US
  • on the Web www.amstock.com
  • in writing at Operations Center, 6201 15th Avenue, Brooklyn, NY 11219

How can I research my historical cost basis on FEI Company shares?

Please see the Historical Price Lookup page on Thermo Fisher Scientific Inc.’s website for detail.

When did the acquisition of Life Technologies Corporation officially close?

The acquisition officially closed on February 3, 2014.

What will I receive in exchange for my Life Technologies Corporation shares?

In accordance with the terms of the acquisition agreement, Life Technologies Corporation shareholders will receive $76.13 in cash per common share.

I hold shares of Life Technologies Corporation. When can I expect to receive payment for my shares?

If you are a shareholder and have a stock certificate, you will receive a letter of transmittal from American Stock Transfer and Trust Company (AST). They were mailed out on February 7, 2014. You will need to complete the forms contained in the mailing and return them to AST to receive payment.

If you are a shareholder who owns shares beneficially through a bank or broker, the funds were transferred to DTC on February 5, 2014, and will be disseminated to all banks and brokers accordingly. Please check your account or contact your broker for more details.

I hold some of my shares of Life Technologies Corporation common stock in certificate form. Do I need to do anything with my Life Technologies stock certificate(s)?

Yes. You will need to surrender your Life Technologies Corporation stock certificate(s) to the Paying Agent, American Stock Transfer & Trust Company (AST). If you hold physical stock certificate(s), you will be receiving a separate mailing from AST for this transaction, with detailed instructions on how to exchange your Life Technologies Corporation stock certificate(s).

What do I do if I hold shares of Life Technologies Corporation common stock with my broker or custodian bank?

Your broker or custodian bank will exchange them for you. Please contact them directly for verification.

Who should I contact if I have questions about the exchange of my Life Technologies Corporation common stock?

Any questions regarding the exchange of Life Technologies Corporation common stock should be directed to American Stock Transfer & Trust Company, the Paying Agent. You may contact them as follows:
by Phone 1-800-937-5449 within the US or 1-718-921-8200 outside of the US
on the Web www.amstock.com
in writing at Operations Center, 6201 15th Avenue, Brooklyn, NY 11219

How can I research my historical cost basis on Life Technologies Corporation shares?

Please see the Historical Price Lookup page on Thermo Fisher Scientific Inc.’s website for detail.

Thermo Fisher Scientific At a Glance

NYSE: TMO (Common Stock)Aug 18, 2017 04:02 PM

Exchange NYSE (US Dollar)NYSE

Price 172.57

Change -0.32  (-0.18%)

Volume 1,182,702

% Change

Intraday High 174.36

52 Week High 182.87

Intraday Low 172.15

52 Week Low 139.07

Today's Open 172.56

Previous Close 172.89

Minimum 20 minute delay

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support.

The world leader in serving science